HANGZHOU TIGERMED CO. H 1 (5HZ1) — Tangible Net Worth Ratio
HANGZHOU TIGERMED CO. H 1 (5HZ1) has a Tangible Net Worth Ratio of 99.0% as of March 2026. This metric is calculated by deducting intangible assets (€254.01 Million) from net assets (€24.56 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See HANGZHOU TIGERMED CO. H 1 (5HZ1) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
HANGZHOU TIGERMED CO. H 1 Tangible Net Worth Ratio (2021–2025)
This chart shows how HANGZHOU TIGERMED CO. H 1's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 99.0%, reflecting net assets of €24.56 Billion with intangible assets of €254.01 Million EUR. See 5HZ1 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for HANGZHOU TIGERMED CO. H 1 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for HANGZHOU TIGERMED CO. H 1 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see HANGZHOU TIGERMED CO. H 1 market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.9% | €24.26 Billion | €276.31 Million | €28.36 Billion | ▲ +0.3 pp |
| 2024 | 98.6% | €24.06 Billion | €336.88 Million | €28.67 Billion | ▲ +0.1 pp |
| 2023 | 98.5% | €24.45 Billion | €371.13 Million | €29.68 Billion | ▼ 0.0 pp |
| 2022 | 98.5% | €22.68 Billion | €338.12 Million | €27.45 Billion | ▼ -0.3 pp |
| 2021 | 98.8% | €20.61 Billion | €250.64 Million | €23.74 Billion | — |